BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Waltham, MA, Apr 7, 2022 – (JCN Newswire via SEAPRWire.com) – BostonGene today announced the completion of $150 million in Series B funding. NEC Corporation (TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industrial Partners. The capital will be used to scale BostonGene’s growth, including continued innovation, clinical and research... » read more
